Literature DB >> 12491136

Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity.

A A Shahin1, S Abdoh, M Abdelrazik.   

Abstract

OBJECTIVE: To determine serum levels of prolactin (PRL) and thyroid hormones and to investigate the correlation between these hormones and different disease manifestations in patients with systemic sclerosis (SSc).
METHODS: Twenty four patients with SSc (23 women, mean age 37.7+/-12.7) were subjected to thyroid hormones assessment. Prolactin (PRL) was assessed in 23 female patients. The patients were evaluated regarding different disease manifestations. Fifteen normal female volunteers were involved as controls.
RESULTS: Serum levels of PRL in all patients was significantly higher than controls (16.75+/-9.06 for patients vs. 11.6+/-4.5 for controls with p<0.001). Eight patients out of 23 (34.8%) showed hyperprolactinemia. In patients with diffuse SSc (dSSc), PRL levels showed significant correlation with the rate of skin tethering (r = +0.72, p<0.01) and abnormal left ventricular filling pattern (decreasing E/A ratio), i.e., occurrence of diastolic dysfunction (r = +0.65, p<0.05). Hyperprolactinemia in all patients correlated significantly with disease duration (r = -0.42, p<0.05). Mean serum levels of free thyroxin (FT4) in all patients were significantly lower than the control group(7.46+/-2.7 for patients vs 10.47+/-2.5 with p<0.001). Eight out of all 24 patients (33.3%) showed hypothyroidism. In group A (duration<3 years); FT4 levels correlated significantly with Dlco% (r = +0.90, p<0.01). While in group B (duration>3 years), T4 hypothyroidism correlated significantly with hand joint restriction of motion (r = +0.66, p<0.01). Serum levels of triiodothironine (FT3) in all patients were nonsignificantly lower than the control group (4.8+/-2.3 for patients vs 5.3+/-1.9 for controls, P = NS). Three patients out of 24 (12.5%) showed T3 thyrotoxicosis. Serum levels of T3 correlated significantly with liver enzyme elevations (r = +0.46, p<0.05) and ESR (r = +0.41, p<0.05).
CONCLUSION: This study demonstrates the close association between PRL or thyroid hormones and some organ involvement in SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12491136     DOI: 10.1007/s00393-002-0413-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  10 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 3.  Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?

Authors:  Vânia Vieira Borba; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2019-01-11       Impact factor: 2.980

4.  Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

Authors:  John C Katsantonis; John Protopsaltis; Stelios Kokkoris; Paris Brestas; Kyriaki Aroni; Symeon Tournis; Gregory Giannoulis
Journal:  Rheumatol Int       Date:  2008-04-24       Impact factor: 2.631

Review 5.  Prolactin and autoimmunity.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Carmen Navarro
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 6.  Associations between Systemic Sclerosis and Thyroid Diseases.

Authors:  Poupak Fallahi; Ilaria Ruffilli; Dilia Giuggioli; Michele Colaci; Silvia Martina Ferrari; Alessandro Antonelli; Clodoveo Ferri
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-03       Impact factor: 5.555

7.  The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients.

Authors:  Yathao Paolee; Chingching Foocharoen; Suranut Charoensri; Mayfong Mayxay; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

8.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

Review 9.  Prolactin and Autoimmunity.

Authors:  Vânia Vieira Borba; Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

10.  Elevated plasma/serum levels of prolactin in patients with systemic sclerosis: A systematic review and meta-analysis.

Authors:  Yang Wu; Meng-Lei Li; Hua-Jing Han; Li-Jun Huang; Yong He
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.